Essential fatty acids in the plasma phospholipids of patients with atopic eczema.
We have measured all the essential fatty acids (EFA) in plasma phospholipids in forty-one adults with atopic eczema and fifty normal controls. The major dietary n-6 EFA, linoleic acid, was significantly elevated, but all its metabolites, 18:3n-6, 20:3n-6, 20:4n-6, 22:4n-6, and 22:5n-6 were significantly reduced. The major dietary n-3 EFA, alpha-linolenic acid, was also elevated, though not significantly, while all its metabolites were also significantly reduced. These observations suggest that atopic eczema is associated not with any defect of EFA intake, but with abnormal metabolism, possibly involving the enzyme delta-6-desaturase. Treatment with oral evening primrose oil produced partial correction of the n-6 EFA abnormality, but had no effect on the n-3 EFAs.
D000328:Adult; D003876:Dermatitis, Atopic / Q000097:blood* / Q000188:drug therapy; D003879:Dermatologic Agents / Q000627:therapeutic use; D005228:Fatty Acids, Essential / Q000097:blood*; D005231:Fatty Acids, Unsaturated / Q000627:therapeutic use; D005260:Female; D006801:Humans; D000960:Hypolipidemic Agents / Q000627:therapeutic use; D019787:Linoleic Acid; D008041:Linoleic Acids / Q000097:blood; D008042:Linolenic Acids / Q000097:blood; D008297:Male; D031665:Oenothera biennis; D010743:Phospholipids / Q000097:blood*; D010938:Plant Oils; D017962:alpha-Linolenic Acid; D017965:gamma-Linolenic Acid
D003879:Dermatologic Agents; D005228:Fatty Acids, Essential; D005231:Fatty Acids, Unsaturated; D000960:Hypolipidemic Agents; D008041:Linoleic Acids; D008042:Linolenic Acids; D010743:Phospholipids; D010938:Plant Oils; D017962:alpha-Linolenic Acid; C028498:evening primrose oil; D017965:gamma-Linolenic Acid; D019787:Linoleic Acid